- Investing Ideas
- /
- Pharmaceuticals & Biotech Consumer Discretionary
Pharmaceuticals & Biotech Consumer Discretionary
Results
1272
0 new
All the companies in the consumer discretionary sector including household durables, leisure products and luxury goods.
1,272 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ALLO | US$2.91 | 3.9% | -8.2% | US$608.5m | US$9.28 | PS9361.8x | E5.5% | n/a | ||
ALMS | US$11.16 | -2.7% | n/a | US$607.1m | US$32.33 | PE-3.2x | E-15.3% | n/a | ||
ARCT | US$22.03 | 6.9% | -13.8% | US$595.7m | US$77.26 | PS3.6x | E68.2% | n/a | ||
MLYS | US$11.90 | 1.6% | 25.1% | US$591.7m | US$33.00 | PB2x | E-8.7% | n/a | ||
TRDA | US$16.45 | 12.1% | 4.1% | US$578.8m | US$23.90 | PE5.5x | E-57.0% | n/a | ||
LXRX | US$1.60 | -3.6% | 46.8% | US$578.4m | US$6.20 | PS158.9x | E41.0% | n/a | ||
YMAB | US$12.95 | -5.7% | 137.6% | US$577.2m | US$20.89 | PS6.7x | E-20.0% | n/a | ||
FDMT | US$10.83 | -9.0% | -14.9% | US$562.8m | US$50.00 | PS27.8x | E-10.7% | n/a | ||
RVNC | US$5.36 | -7.7% | -53.3% | US$561.9m | US$9.23 | PS2.2x | E72.2% | n/a | ||
THRD | US$13.50 | -10.4% | 111.3% | US$554.8m | US$19.00 | PB2.2x | E-22.9% | n/a | ||
QTTB | US$46.00 | -6.1% | n/a | US$554.8m | US$77.80 | PB16.6x | E-30.7% | n/a | ||
TALS | US$27.20 | -4.9% | 91.5% | US$553.2m | US$200.00 | PB3.7x | n/a | n/a | ||
FREQ | US$14.98 | 29.1% | -87.5% | US$547.3m | n/a | PB14.9x | E-4.7% | n/a | ||
URGN | US$12.90 | -4.7% | -7.9% | US$543.3m | US$43.10 | PS6.4x | E55.1% | n/a | ||
PROK | US$1.86 | -24.4% | -59.4% | US$538.8m | US$4.67 | PE-6.1x | E-12.1% | n/a | ||
SNDL | US$2.02 | 1.5% | 6.3% | US$535.5m | US$3.66 | PB0.6x | E111.6% | n/a | ||
RGNX | US$10.80 | -7.6% | -34.4% | US$533.8m | US$39.64 | PS6x | E30.5% | n/a | ||
KALV | US$12.34 | 17.6% | 28.1% | US$533.3m | US$30.17 | PB3.1x | E60.6% | n/a | ||
CELC | US$14.40 | -3.0% | 57.5% | US$533.2m | US$28.57 | PB3x | E27.0% | n/a | ||
TKCI | US$1.25 | 0% | n/a | US$529.5m | n/a | n/a | n/a | n/a | ||
NGNE | US$40.33 | -1.0% | n/a | US$524.0m | US$51.40 | PE221.7x | E-32.5% | n/a | ||
FHTX | US$9.36 | -6.3% | 87.2% | US$517.9m | US$16.00 | PS14.7x | E4.1% | n/a | ||
OCS | US$12.31 | 2.6% | 11.9% | US$514.0m | US$28.92 | PS496.1x | E-3.5% | n/a | ||
OABI | US$4.25 | -3.8% | -18.1% | US$502.2m | US$10.00 | PS23.1x | E28.9% | n/a |